For example, the identification of IDH mutations has profoundly affected the classification and prognosis of gliomas; however, turning these molecular insights into surgical decisions during operative cases requires an unprecedented level of synthesis of genomic and surgical workflows [34,35]. Here, IDH1 is linked to central nervous system cancer.